Joanna C. Masters, PharmD, FCP

Senior Director, Pharmacometrics - Oncology
Pfizer Inc

Poster(s):

• (M-071) Dose optimization framework to estimate benefit-risk for oncology compounds: an integrated population model framework incorporating PK, safety, efficacy and impact of dose modifications
  Monday, October 20, 2025

  7:00 AM - 5:00 PM MDT